MarketInOut Stock Screener Log In | Sign Up

Wanbury Ltd

Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/28/2026 15:29
Wanbury Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Market Capitalization6,240.55 mln
Float17.31 mln

EPS

16.28
Robust

P / E

10.69
Fair value

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-1.62
Likely manipulated

Relative Strength

20 / 100
Significantly lagging

Debt / Equity

1.57
High leverage

Business Description

Founded in 1988 and based in Navi Mumbai, India, Wanbury Limited is a pharmaceutical company that produces and sells medicines both within India and abroad. The company makes finished drug products covering a wide range of health conditions, including infections, pain, digestive disorders, breathing problems, and mental health. It also produces raw pharmaceutical ingredients used by other drug makers, such as compounds for managing diabetes, depression, allergies, and inflammation.

Key Fundamentals

EPS16.28
P/E10.69
ROE53.92
RPS200
ROIC25.18
ROA12.08
Interest Cover2.76
EBITDA, mln959
EV / EBITDA10.20
EV / EBIT12.05
Revenue, mln6,527
EV / Revenue1.50

Quote Details

Last 173.30
Change -2.72 (-1.55%)
Open 177.00
Volume 93,977
Turnover 16,286,215
Average Volume 330,335

Financial Ratios

Pre-Tax Profit Margin8
Current Ratio1.19
Price / Book4.83
Price / Tangible Book4.92
Debt / Equity1.57
Price / Sales1.05
PEG Ratio0.55

Financial Strength

Altman Z-Score2.97
Piotroski F-Score 6 / 9
Beneish M-Score-1.62
Price to Lynch Fair Value0.72
Price to Graham Number1.48
Shiller PE Ratio14.38

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -7.66% 11 / 100   
1 Month -22.96% 5 / 100   
2 Months -48.79% 1 / 100   
6 Months -33.15% 9 / 100   
1 Year -24.6% 37 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog